发明名称 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
摘要 Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4 </SUP>and R<SUP>5 </SUP>are H, alkyl or alkoxyalkyl; R<SUP>6 </SUP>is H, alkyl, hydroxyalkyl or -CH<SUB>2</SUB>F; R<SUP>7</SUP>, R<SUP>8 </SUP>and R<SUP>9 </SUP>are H, alkyl, alkoxy, alkylthio, alkoxyalkyl, halo or -CF<SUB>3</SUB>; and Z is optionally substituted aryl, heteroaryl or heteroaryl-alkyl are disclosed. Also disclosed is the use of compounds of formula I in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.
申请公布号 US2005222164(A1) 申请公布日期 2005.10.06
申请号 US20050135261 申请日期 2005.05.23
申请人 NEUSTADT BERNARD R;HAO JINSONG;LIU HONG;BOYLE CRAIG D;CHACKALAMANNIL SAMUEL;SHAH UNMESH G;STAMFORD ANDREW 发明人 NEUSTADT BERNARD R.;HAO JINSONG;LIU HONG;BOYLE CRAIG D.;CHACKALAMANNIL SAMUEL;SHAH UNMESH G.;STAMFORD ANDREW
分类号 A61P25/16;C07D487/14;(IPC1-7):A61K31/519 主分类号 A61P25/16
代理机构 代理人
主权项
地址